Sreelatha Meleth

University of Alabama at Birmingham

Papers

2

Total Citations

9

H-Index

2

About

Sreelatha Meleth’s research focuses on the early detection and clinical management of cervical precancer, with a particular emphasis on improving triage for women at high risk of cervical cancer. Her major contributions lie in the use of proteomics to differentiate between stages of cervical intraepithelial neoplasia (CIN). In her most cited work, she demonstrated that plasma protein profiles can distinguish between women diagnosed with CIN 1 and CIN 3, offering a potential biomarker-based approach to triage. This is significant because traditional methods—such as cytology and high-risk HPV testing—lack the sensitivity needed to reliably identify women who require immediate intervention. By highlighting distinct protein signatures, her research paves the way for more precise, non-invasive diagnostic tools. Although her citation counts are modest (6 and 3 citations for her top papers), the work addresses a critical gap in cervical cancer prevention: the need for better stratification of precancerous lesions. Her findings have implications for reducing overtreatment of low-grade lesions while ensuring that high-grade lesions are caught early, ultimately contributing to more effective screening programs.

Research Focus

Key Achievements

2
H-Index
2
Papers
9
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Plasma protein profiles differ between women diagnosed with cervical intraepithelial neoplasia (cin) 1 and 3.
6 citations · 2007
📈 Most Prolific Year: 2007 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: University of Alabama at Birmingham

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago